The total return over the past 12 months is -35.84% vs. +16.94% for the S&P 500. So far it's up -37.58% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (35.84%) | +26.92% | +9.70% | (7.74%) | +9.35% | N/A |
| Total Return CAGR | (35.84%) | +26.92% | +9.70% | (7.74%) | +9.35% | N/A |
| Revenue CAGR | +280.50% | +2228.84% | +352.03% | +128.97% | N/A | N/A |
| Net Income CAGR | +265.86% | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | +207.87% | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | +722.93% | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +733.57% | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
CorMedix Inc. (CRMD)
| Year | Start price | End price | CRMD Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $11.63 | $7.26 | (37.58%) | +14.51% | (52.09%) |
| 2025 | $8.10 | $11.63 | +43.58% | +17.72% | +25.86% |
| 2024 | $3.76 | $8.10 | +115.43% | +24.89% | +90.54% |
| 2023 | $4.22 | $3.76 | (10.90%) | +26.19% | (37.09%) |
| 2022 | $4.55 | $4.22 | (7.25%) | (18.17%) | +10.92% |
| 2021 | $7.43 | $4.55 | (38.76%) | +28.74% | (67.50%) |
| 2020 | $7.28 | $7.43 | +2.06% | +18.37% | (16.31%) |
| 2019 | $6.45 | $7.28 | +12.87% | +31.22% | (18.35%) |
| 2018 | $2.50 | $6.45 | +158.00% | (4.56%) | +162.56% |
| 2017 | $7.65 | $2.50 | (67.32%) | +21.70% | (89.02%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
